Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671 | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 / Phase 2 | 2026-09-14 | NCT07815678 |